Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
about
Portal Vein Embolization as an Oncosurgical Strategy Prior to Major Hepatic Resection: Anatomic, Surgical, and Technical ConsiderationsContrast Enhanced MRI in the Diagnosis of HCCMultimodal treatment of hepatocellular carcinoma on cirrhosis: an updateIntraoperative ultrasound in patients with hepatocellular carcinoma: from daily practice to future trendsMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Current management of hepatocellular carcinoma.Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantationResection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcomeSurvival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.A standard definition of major hepatectomy: resection of four or more liver segments.Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection.Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.Functional biomarkers of depression: diagnosis, treatment, and pathophysiologyModifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical TreatmentDoes transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma?Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignanciesHepatocellular carcinoma: natural history, current management, and emerging tools.Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection.Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinomaHepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradePrognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma.Pretreatment assessment of hepatocellular cancer: expert consensus conference.Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes.Preoperative liver function assessments to estimate the prognosis and safety of liver resections.Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options.Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC.Treatment of Liver Cancer.The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes.Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma.Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis.Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma.AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy.
P2860
Q26750812-5076E2E1-0E61-4CB7-9F52-FA12B5493D7EQ26768472-AC123E58-68E8-46DC-812D-EFAC17CAAAFFQ26825172-972EA2BB-91FC-4E6B-B74D-92AC527D66C4Q26825607-581A3727-70A4-45BB-ADBA-F1419C3FB190Q26998606-A4058722-51AC-47B4-A6E0-BB9153986210Q33582165-6E32DFE2-A99A-4298-809D-CF9E5B3D3E15Q33859804-5A9D664C-7986-4D1E-BD82-12E4469D522AQ33893756-532BD2F7-3156-49A4-9F59-CD42724E2248Q34207805-C9A01D5B-E5E1-4C0A-874F-225A8A57854EQ34645408-E4710ED8-3165-4596-B7C5-C1B893AD99DBQ35097619-312C8EB0-6AAC-4C7A-8297-C0C6C17533F7Q35207490-06944B74-A72D-44C0-951F-9FF6B8F235C9Q35207762-AD8FD9DB-748A-4967-8606-FCD299ADEA10Q35356872-B4E3868C-692F-4E88-A1A7-B6D5F53B0D9AQ35867676-3516F143-6364-410A-B6C2-DB3EA79311B9Q36063323-C30D5541-98D7-4F53-A6F3-63886A06AA55Q36120986-1DA10094-A395-4F52-944C-B83F806046C3Q36171275-15E824E2-0399-49CE-BC66-C0846E47CC6CQ36255571-28504007-206C-4FD0-A220-12B5CB99EB08Q36335396-3B0C0DA4-313E-41BB-ACEC-4378A1870884Q36356282-ECC38A98-7D85-4AC8-8897-94171D7FBD10Q37096406-E071D234-1264-4596-A4A2-27F87D7286B1Q37174913-9927DE44-F10A-4D7B-BD3B-6FF3A33223C1Q37522674-CC7B4EA3-3BFF-4C04-965D-AA9AFF906CA0Q37660712-9F100FC9-1B71-409C-88EF-29595CFB68FDQ37768893-EEAEC2AF-157F-42FD-A16A-1641D72DBBF5Q38081075-5ABF38C7-9262-4105-9146-B6C17CEBA0E3Q38087845-34E44980-3045-4B2A-86EF-971120ECD342Q38206274-CB195BD4-59C6-4C68-9915-427034DCEBFAQ38368535-F4A0DA07-0107-4844-ACE7-144A580E467DQ38549768-D0595B2C-5E83-4737-91AF-04A515BE1D24Q38621100-9B176C58-0776-46EC-9B4F-E1FD8740BAD3Q38824638-6E9ED5BD-982F-48ED-8BED-80D88DCE4BA8Q38851408-914F5344-53F6-48A6-AC64-4FBC8416C3ABQ39349696-F9ACB557-06EE-440A-B176-6B760E751C33Q39434012-9C16B774-E90C-47BF-AFDC-927EA1BEB872Q40468451-42591CC9-6287-463A-A560-AFAEEA7BBD1CQ41081521-8F8C18E8-534E-48AB-8978-E386C802FA65Q42412522-3897740E-CADD-4E7C-AD0F-969AF5F0B691Q44233328-2E995AE7-B097-4F6C-A686-EED73B5FFDB8
P2860
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@ast
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@en
type
label
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@ast
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@en
prefLabel
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@ast
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@en
P2093
P2860
P50
P1476
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
@en
P2093
American Hepato-Pancreato-Biliary Association
Antoine Brouquet
Bachir Taouli
Eddie K Abdalla
Elijah Dixon
Reid B Adams
Society for Surgery of the Alimentary Tract
W Scott Helton
P2860
P304
P356
10.1111/J.1477-2574.2010.00181.X
P577
2010-06-01T00:00:00Z